Research ArticleClinical Investigation
An External, Independent Validation of an O-(2-[18F]Fluoroethyl)-l-Tyrosine PET Automatic Segmentation Network on a Single-Center, Prospective Dataset of Patients with Glioblastoma
Nathaniel Barry, Jake Kendrick, Pejman Rowshanfarzad, Ghulam Mubashar Hassan, Roslyn J. Francis, Nicholas Bucknell, Eng-Siew Koh, Andrew M. Scott, Martin A. Ebert, Robin Gutsche, Keith George Ciantar, Norbert Galldiks, Karl-Josef Langen and Philipp Lohmann
Journal of Nuclear Medicine April 2025, jnumed.124.268925; DOI: https://doi.org/10.2967/jnumed.124.268925
Nathaniel Barry
1School of Physics, Mathematics and Computing, University of Western Australia, Crawley, Western Australia, Australia;
2Centre for Advanced Technologies in Cancer Research, Perth, Western Australia, Australia;
Jake Kendrick
1School of Physics, Mathematics and Computing, University of Western Australia, Crawley, Western Australia, Australia;
2Centre for Advanced Technologies in Cancer Research, Perth, Western Australia, Australia;
3Australian Centre for Quantitative Imaging, Medical School, University of Western Australia, Crawley, Western Australia, Australia;
Pejman Rowshanfarzad
1School of Physics, Mathematics and Computing, University of Western Australia, Crawley, Western Australia, Australia;
2Centre for Advanced Technologies in Cancer Research, Perth, Western Australia, Australia;
Ghulam Mubashar Hassan
1School of Physics, Mathematics and Computing, University of Western Australia, Crawley, Western Australia, Australia;
3Australian Centre for Quantitative Imaging, Medical School, University of Western Australia, Crawley, Western Australia, Australia;
Roslyn J. Francis
3Australian Centre for Quantitative Imaging, Medical School, University of Western Australia, Crawley, Western Australia, Australia;
4Department of Nuclear Medicine, Royal Brisbane and Women’s Hospital, Herston, Queensland, Australia;
Nicholas Bucknell
5Department of Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia;
Eng-Siew Koh
6Department of Radiation Oncology, Liverpool and Macarthur Cancer Therapy Centres, Liverpool, New South Wales, Australia;
7South Western Sydney Clinical School, University of New South Wales, Warwick Farm, New South Wales, Australia;
Andrew M. Scott
8Department of Molecular Imaging and Therapy, Austin Health, and University of Melbourne, Melbourne, Victoria, Australia;
9Olivia Newton-John Cancer Research Institute, and School of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia;
Martin A. Ebert
1School of Physics, Mathematics and Computing, University of Western Australia, Crawley, Western Australia, Australia;
2Centre for Advanced Technologies in Cancer Research, Perth, Western Australia, Australia;
3Australian Centre for Quantitative Imaging, Medical School, University of Western Australia, Crawley, Western Australia, Australia;
5Department of Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia;
Robin Gutsche
10Institute of Neuroscience and Medicine, Forschungszentrum Juelich GmbH, Juelich, Germany;
Keith George Ciantar
10Institute of Neuroscience and Medicine, Forschungszentrum Juelich GmbH, Juelich, Germany;
11Institute of Imaging and Computer Vision, RWTH Aachen University, Aachen, Germany;
Norbert Galldiks
10Institute of Neuroscience and Medicine, Forschungszentrum Juelich GmbH, Juelich, Germany;
12Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany;
13Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Germany; and
Karl-Josef Langen
10Institute of Neuroscience and Medicine, Forschungszentrum Juelich GmbH, Juelich, Germany;
13Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Germany; and
14Department of Nuclear Medicine, University Hospital RWTH Aachen, Aachen, Germany
Philipp Lohmann
10Institute of Neuroscience and Medicine, Forschungszentrum Juelich GmbH, Juelich, Germany;
14Department of Nuclear Medicine, University Hospital RWTH Aachen, Aachen, Germany

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 66, Issue 4
April 1, 2025
An External, Independent Validation of an O-(2-[18F]Fluoroethyl)-l-Tyrosine PET Automatic Segmentation Network on a Single-Center, Prospective Dataset of Patients with Glioblastoma
Nathaniel Barry, Jake Kendrick, Pejman Rowshanfarzad, Ghulam Mubashar Hassan, Roslyn J. Francis, Nicholas Bucknell, Eng-Siew Koh, Andrew M. Scott, Martin A. Ebert, Robin Gutsche, Keith George Ciantar, Norbert Galldiks, Karl-Josef Langen, Philipp Lohmann
Journal of Nuclear Medicine Apr 2025, jnumed.124.268925; DOI: 10.2967/jnumed.124.268925
An External, Independent Validation of an O-(2-[18F]Fluoroethyl)-l-Tyrosine PET Automatic Segmentation Network on a Single-Center, Prospective Dataset of Patients with Glioblastoma
Nathaniel Barry, Jake Kendrick, Pejman Rowshanfarzad, Ghulam Mubashar Hassan, Roslyn J. Francis, Nicholas Bucknell, Eng-Siew Koh, Andrew M. Scott, Martin A. Ebert, Robin Gutsche, Keith George Ciantar, Norbert Galldiks, Karl-Josef Langen, Philipp Lohmann
Journal of Nuclear Medicine Apr 2025, jnumed.124.268925; DOI: 10.2967/jnumed.124.268925
Jump to section
Related Articles
Cited By...
- No citing articles found.